I couldn't take that bet without odds. B very well may be the first to partner and I wouldn't be surprised one bit. J&J has always been at the top of my list because of the belief that they are the BP with the CDA for implant application with us. Howsomever, I think there's a lot more mileage in B and it would make fiscal sense in maximizing shareholder wealth to partner P and take some quick bucks and get off this freaking exchange and develop B through the phase3. My $.02, but with money on the balance sheet, Ph3 B would go a lot quicker with a LOT more outside interest. There's no shortage of $$$ in the sector, just a shortage of companies that have it. Not much longer, IMO.